In the meantime, our pilot study on the gene expression profile of the MDS CD34+ cells by microarray showed that the transcriptions of Runx1 and Pten were down-regulated in MDS CD34+ cells compared to the non-MDS normal controls. The gene discussed is CD34; the disease is myelodysplastic syndrome.